Bohai Pharmaceuticals Group, Inc. (BOPH) is engaged in the production, manufacturing and distribution of herbal pharmaceuticals based on traditional Chinese medicine (TCM), in the People�s Republic of China. The Company�s operations are exclusively in China. The Company's medicines address rheumatoid arthritis, viral infections, gynecological diseases, cardio vascular issues and respiratory diseases. The Company obtained Drug Approval Numbers for 29 varieties of traditional Chinese herbal medicines. The Company produces 19 varieties of approved traditional Chinese herbal medicines in seven delivery systems: tablets, granules, capsules, formulations, concentrated powder, tincture and medicinal wine. Of these 19 products, 12 are prescription drugs and seven are over the counter (OTC) products. In August 2011, the Company obtained DANs for another five varieties. On August 8, 2011, the Company acquired Yantai Tianzheng Pharmaceutical Co., Ltd.